Canada - Australia Parallel Review Project

A Parallel Review Project is being undertaken between the Biologics and Genetic Therapies Directorate (BGTD) of Health Canada and the Therapeutic Goods Administration (TGA) Australia.

This is a joint project that aims to enhance cooperation between regulators in various jurisdictions around the world. The purpose of this project is to provide a mechanism for sharing information on evaluation processes between the BGTD and TGA.

The following documents provide more information on this project.

• Industry and Agency Obligations - Canada and Australia Parallel Review Project